接受免疫检查点抑制剂治疗的非小细胞肺癌患者伴既存自身免疫疾病的风险与生存分析：基于全国多中心回顾性研究（NEJ047）的逆概率加权生存分析
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Aug
作者:
DOI:10.1016/j.lungcan.2024.107894
摘要
AI正在翻译并加载中文摘要...